F

fingerpaint

Healthcare marketing and commercialization agency

Overview

Fingerpaint Group is a healthcare marketing and commercialization agency that serves biopharma, biotech, medical devices, and animal health with analytics-enabled, integrated solutions. Its work combines creative, branding, omnichannel marketing, medical communications, market access, and media planning across three segments—Marketing Services, Medical, and Market Access—to support products from early strategy through post-launch. The company differentiates itself with a people-first philosophy, broad end-to-end capabilities, and growth through strategic acquisitions that enable coordinated, cross-discipline campaigns at scale. Its goal is to help clients bring products to market efficiently and maximize value across a product’s lifecycle by aligning scientific communications, marketing execution, and market access into one integrated approach.

Significant Headcount Growth

Work here?Claim your company

About fingerpaint

Simplify's Rating
Why fingerpaint is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Data & AnalyticsConsultingBiotechnologyHealthcare

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Hanover Township, New Jersey

Founded

2008

Get referred to fingerpaint

See people who can refer or advise you

Simplify Jobs

Simplify's take

What believers are saying

  • Revenue reached $225.1 million in 2025, up 21% year over year.
  • September 2026 Wyatt Gotbetter hire deepens market access before launch-heavy 2027 cycles.
  • May 2026 SBTi validation and AI leadership strengthen recruiting with enterprise clients.

What critics are saying

  • Knox Lane reportedly explored a sale in January 2026, threatening leadership continuity.
  • Integration across roughly ten acquisitions strains margins, culture, and delivery consistency.
  • If large pharma clients consolidate vendors, Fingerpaint loses its platform advantage fast.

What makes fingerpaint unique

  • One platform spans marketing, medical, and market access for full commercialization.
  • 2026 leadership hires unify operations, strategy, technology, and payer expertise.
  • 95% of top 20 global pharma clients proves elite access and trust.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Hybrid Work Options

Growth & Insights and Company News

6 month growth

6%

1 year growth

7%

2 year growth

7%
PR Newswire
Sep 22nd, 2026
Fingerpaint Group appoints Wyatt Gotbetter as president of market access

Fingerpaint Group has appointed Wyatt Gotbetter as president of market access. The 2026 Med Ad News Network of the Year winner made the announcement on 22 September. Gotbetter will lead Fingerpaint Market Access, The MYND Group, and BlackPoint Consulting Group. The role encompasses payer strategy, health economics, patient support, and launch execution. Gotbetter brings nearly 30 years of experience in new-product commercialisation, payer strategy, and health economics. He most recently served as global head of evidence, value, and access at Cytel. Previously, he was senior vice president at Parexel, overseeing market access and real-world evidence consulting. Earlier in his career, Gotbetter led new-product commercialisation at Biogen and built the payer relations function at Boston Scientific.

PR Newswire
Jun 16th, 2026
Fingerpaint Group appoints Latifa Alladina as general manager of Fingerpaint Marketing

Fingerpaint Group has appointed Latifa Alladina as general manager of Fingerpaint Marketing. Alladina joins from Area 23, where she served nearly 11 years, rising to EVP and executive director. She fills the position vacated when Tracy Blackwell was promoted to president of Marketing Services. Alladina holds a PharmD from Duquesne University and brings over 25 years of experience spanning client-side brand leadership, senior scientific roles, strategy and client service. Her therapeutic expertise includes rare disease, neurology and immunology. Previously, she worked at Digitas Health and Remedy Edge. Fingerpaint Marketing is the largest solution within Fingerpaint Group, which closed 2025 with record revenue and 21% growth, marking its 15th consecutive year on MM+M's list of top 100 agencies in North America.

PR Newswire
Jun 2nd, 2026
Fingerpaint Group appoints Sarah Cherng as chief technology & product officer

Fingerpaint Group has appointed Sarah Cherng as Chief Technology & Product Officer. Cherng brings over 20 years of experience in enterprise data science and AI leadership across healthcare, pharmaceutical and consumer sectors. Most recently, Cherng served as Chief Artificial Intelligence Officer at Aura, leading the engineering and AI organisation through a successful liquidity event. Previously at Estée Lauder Companies, she delivered over $200 million in business value, building an enterprise data platform and generating machine learning-driven insights. She also directed Global Oncology Data and Analytics at Merck, supporting a $16 billion-plus revenue portfolio. In her new role, Cherng will shape Fingerpaint's technology and AI strategy, modernise data infrastructure and guide clients through AI complexity. Fingerpaint Group is a top 20 healthcare agency partnering with 95% of the top 20 global pharmaceutical companies.

PR Newswire
Nov 11th, 2025
Fingerpaint Group Boosts Medical Communications Capabilities With Acquisition of L&M Healthcare Communications

The acquisition enhances Fingerpaint Group's comprehensive medical communications offeringCEDAR KNOLLS, N.J., Nov. 11, 2025 /PRNewswire/ -- Fingerpaint Group is excited to announce the acquisition of L&M Healthcare Communications, a full-service, New Jersey-based medical communications agency serving biotech and pharmaceutical companies. Details of the transaction were not disclosed.In 2020, Fingerpaint Group partnered with the San Francisco-based private equity firm Knox Lane to accelerate its trajectory through organic growth and strategic partnerships. Since then, Fingerpaint Group has experienced exponential growth in its roster of capabilities, customers, and talent.For over 5 years, Fingerpaint Group has been steadily building a robust offering in medical communications and medical affairs, reflecting its commitment to supporting clients throughout the full product lifecycle. The addition of L&M Healthcare Communications brings more than two decades of experience with leading pharma companies, providing specialized knowledge and complementary capabilities that will further this mission."Welcoming L&M Healthcare Communications into our organization is a step toward the future we're building in medical communications," said Javeria Shahab, President of Fingerpaint Medical. "Their expertise in peer-to-peer educational programs and speaker bureau services strengthens our ability to deliver innovative, more connected solutions."L&M Healthcare Communications will become part of Fingerpaint Medical's Medical Communications portfolio, expanding the group's ability to deliver comprehensive and impactful offerings."Joining Fingerpaint Group is a defining moment for our team and the clients we serve," stated Adam Margolis, Chief Executive Officer and Managing Partner of L&M

PR Newswire
Mar 21st, 2023
Fingerpaint Group Acquires PharmaHEALTHLabs, Growing Its Oncology and Biologics Capabilities

/PRNewswire/ -- Fingerpaint Group, an integrated collective of healthcare companies that offer commercialization solutions spanning the full product life...

Recently Posted Jobs

Sign up to get curated job recommendations

fingerpaint is Hiring for 33 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs